Literature DB >> 11585353

Glucocorticoid excess during adolescence leads to a major persistent deficit in bone mass and an increase in central body fat.

V Abad1, G P Chrousos, J C Reynolds, L K Nieman, S C Hill, R S Weinstein, G M Leong.   

Abstract

Endogenous Cushing's syndrome (CS) in children causes growth retardation, decreased bone mass, and increased total body fat. No prospective controlled studies have been performed in children to determine the long-term sequelae of CS on peak bone mass and body composition. A 15-year-old girl with Cushing disease (CD), and her healthy identical co-twin, were followed for 6 years after the CD was cured. At the 6-year follow-up both twins had areal bone mineral density (BMD) and body composition determined by dual-energy X-ray absorptiometry (DXA) and three-dimensional quantitative computed tomography (3DQCT). Z scores for height, weight, and body mass index (BMI) were -2.3, -0.8 and 0.2, and 1.2, 0.2, and -0.6, in the twin with CD and her co-twin, respectively. In the twin with CD, areal BMD and bone mineral apparent density (BMAD) at different sites varied from 0.7 to 3 SD below her co-twin. Volumetric lumbar spine bone density Z score was -0.75 and 1.0, and total body, abdominal visceral, and subcutaneous fat (%) was 42, 10, and 41 versus 26, 4, and 17 in the twin with CD and her co-twin, respectively. The relationship between total body fat and L2-L4 BMAD was inverse in the twin with CD (p < 0.05), which by contrast in her co-twin was opposite and direct (p < 0.001). In the twin with CD, despite cure, there was a persistent deficit in bone mass and increase in total and visceral body fat. These observations suggest that hypercortisolism (exogenous or endogenous) during adolescence may have persistent adverse effects on bone and fat mass.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585353     DOI: 10.1359/jbmr.2001.16.10.1879

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  19 in total

1.  Body composition and vertebral fracture risk in female patients treated with glucocorticoid.

Authors:  H Kaji; T Tobimatsu; J Naito; M-F Iu; M Yamauchi; T Sugimoto; K Chihara
Journal:  Osteoporos Int       Date:  2005-12-31       Impact factor: 4.507

Review 2.  Bone density in the adolescent athlete.

Authors:  Madhusmita Misra
Journal:  Rev Endocr Metab Disord       Date:  2008-04-12       Impact factor: 6.514

3.  Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice.

Authors:  Innocence Harvey; Erin J Stephenson; JeAnna R Redd; Quynh T Tran; Irit Hochberg; Nathan Qi; Dave Bridges
Journal:  Endocrinology       Date:  2018-06-01       Impact factor: 4.736

4.  Changes in osteocyte density correspond with changes in osteoblast and osteoclast activity in an osteoporotic sheep model.

Authors:  M R Zarrinkalam; A Mulaibrahimovic; G J Atkins; R J Moore
Journal:  Osteoporos Int       Date:  2011-05-31       Impact factor: 4.507

Review 5.  Cushing's syndrome and bone.

Authors:  Tatiana Mancini; Mauro Doga; Gherardo Mazziotti; Andrea Giustina
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

6.  Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease.

Authors:  S Scommegna; J P Greening; H L Storr; K M Davies; N J Shaw; J P Monson; A B Grossman; M O Savage
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

7.  Anthropometric measures and fasting insulin levels in children before and after cure of Cushing syndrome.

Authors:  Margaret F Keil; Jennifer Graf; Nirmal Gokarn; Constantine A Stratakis
Journal:  Clin Nutr       Date:  2011-12-07       Impact factor: 7.324

8.  Metabolic effects of prazosin on skeletal muscle insulin resistance in glucocorticoid-treated male rats.

Authors:  Emily C Dunford; Erin R Mandel; Sepideh Mohajeri; Tara L Haas; Michael C Riddell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-09       Impact factor: 3.619

9.  Voluntary exercise improves metabolic profile in high-fat fed glucocorticoid-treated rats.

Authors:  Jacqueline L Beaudry; Emily C Dunford; Erwan Leclair; Erin R Mandel; Ashley J Peckett; Tara L Haas; Michael C Riddell
Journal:  J Appl Physiol (1985)       Date:  2015-03-19

10.  Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome.

Authors:  L Füto; J Toke; A Patócs; A Szappanos; I Varga; E Gláz; Z Tulassay; K Rácz; M Tóth
Journal:  Osteoporos Int       Date:  2007-11-28       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.